{"version":"1.0","type":"link","title":"Thoracic radiotherapy plus maintenance durvalumab after first line carboplatin and etoposide plus durvalumab in extensive-stage disease small cell lung cancer (ES-SCLC) - A multicenter single arm open label phase II trial (SAKK 15/19).","author_name":"Addeo A 외","author_url":"https://prs-insight.online/author/Addeo%20A","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/99368","thumbnail_width":1200,"thumbnail_height":630}